Amundi Acquires 50,847 Shares of Houlihan Lokey, Inc. $HLI

Amundi lifted its holdings in shares of Houlihan Lokey, Inc. (NYSE:HLI) by 404.0% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 63,433 shares of the financial services provider’s stock after acquiring an additional 50,847 shares during the quarter. Amundi owned approximately 0.09% of Houlihan Lokey worth $9,725,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HLI. Baird Financial Group Inc. bought a new position in shares of Houlihan Lokey during the fourth quarter valued at approximately $546,000. Cetera Investment Advisers raised its holdings in shares of Houlihan Lokey by 11.8% during the fourth quarter. Cetera Investment Advisers now owns 20,727 shares of the financial services provider’s stock valued at $3,600,000 after acquiring an additional 2,183 shares in the last quarter. Cubist Systematic Strategies LLC bought a new stake in Houlihan Lokey during the 4th quarter valued at approximately $353,000. D. E. Shaw & Co. Inc. grew its holdings in shares of Houlihan Lokey by 49.8% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 13,477 shares of the financial services provider’s stock worth $2,340,000 after acquiring an additional 4,483 shares during the period. Finally, Ethic Inc. purchased a new position in shares of Houlihan Lokey during the 4th quarter worth approximately $831,000. Institutional investors own 78.07% of the company’s stock.

Insider Transactions at Houlihan Lokey

In other news, General Counsel Christopher M. Crain sold 500 shares of the stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $196.22, for a total value of $98,110.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Chairman Irwin Gold sold 5,000 shares of the stock in a transaction on Monday, June 30th. The stock was sold at an average price of $182.81, for a total value of $914,050.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 45,500 shares of company stock valued at $9,010,160. Insiders own 22.83% of the company’s stock.

Houlihan Lokey Trading Down 0.8%

Houlihan Lokey stock opened at $196.80 on Wednesday. Houlihan Lokey, Inc. has a 12 month low of $137.99 and a 12 month high of $201.63. The company has a market capitalization of $13.84 billion, a price-to-earnings ratio of 33.13 and a beta of 0.86. The business’s fifty day simple moving average is $193.25 and its two-hundred day simple moving average is $175.64.

Houlihan Lokey (NYSE:HLI) last released its earnings results on Tuesday, July 29th. The financial services provider reported $2.14 EPS for the quarter, topping analysts’ consensus estimates of $1.69 by $0.45. Houlihan Lokey had a return on equity of 23.75% and a net margin of 16.46%.The firm had revenue of $605.35 million for the quarter, compared to analysts’ expectations of $573.07 million. During the same period in the prior year, the firm posted $1.22 earnings per share. The company’s quarterly revenue was up 17.8% on a year-over-year basis. On average, equities research analysts predict that Houlihan Lokey, Inc. will post 5.98 EPS for the current year.

Houlihan Lokey Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Tuesday, September 2nd will be paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend is Tuesday, September 2nd. Houlihan Lokey’s dividend payout ratio is currently 40.40%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Morgan Stanley lifted their price target on Houlihan Lokey from $192.00 to $213.00 and gave the company an “overweight” rating in a research report on Monday. Wells Fargo & Company increased their price objective on Houlihan Lokey from $185.00 to $209.00 and gave the stock an “overweight” rating in a report on Friday, July 11th. Wall Street Zen downgraded Houlihan Lokey from a “buy” rating to a “hold” rating in a report on Saturday, August 2nd. Finally, Keefe, Bruyette & Woods upgraded Houlihan Lokey from a “hold” rating to a “moderate buy” rating and increased their price objective for the stock from $185.00 to $232.00 in a report on Monday, July 14th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Houlihan Lokey presently has a consensus rating of “Moderate Buy” and a consensus target price of $210.60.

Houlihan Lokey Profile

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.